Intralesional administration of betamethasone dipropionate, 5 mg/ml, was a safe and effective method of treating resistant localized lesions of patients with steroid-responsive dermatoses. Following a single injection, three-quarters of the patients had a good to excellent response which was maintained for the eight-week follow-up period.
Get full access to this article
View all access options for this article.
References
1.
BadenH PParrishJ A (1977) Psoriasis. In: Current Therapy. Edited by ConnH F. W B Saunders Company, Philadelphia.
2.
CohenL K (1977) Neurodermatitis. In: Current Therapy. Edited by ConnH F. W B Saunders Company, Philadelphia.
3.
CoskeyR J (1977) Lichen planus. In: Current Therapy. Edited by ConnH F. W B Saunders Company, Philadelphia.
4.
CourbilJRodierJDengneLMerrienVDaboTLacour-GayetF (1976) A propos du traitement des cheloides anciennes (Treatment for stabilized keloids.)Bull. Soc. Med. Afr. Noire. Lang. Fr.21, 201.
5.
FosnaughR P (1977) Keloid. In: Current Therapy. Edited by ConnH F. W B Saunders Company, Philadelphia.
6.
HurleyH J (1975) Dermatologic therapy. In: Dermatology, Vol II. Edited by MoschellaS LPillsburyD MHurleyH J. W B Saunders Company, Philadelphia.
7.
JarrettM TSparkR FArndtK A (1974) Effect of intradermal steroids on pituitary-adrenal axis and skin. Journal of Investigative Dermatology62, 463.
8.
MaibachH IStoughtonR B (1975) Topical corticosteroids. In: Steroid Therapy. Edited by AzaranoffD L. W B Saunders Company, Philadelphia.
9.
NoojinR O (1966) Intralesional therapy with betamethasone. Archives of Dermatology93, 463.
10.
ReesR B JArnoldH L (1975) Report: American Academy of Dermatology, December 7–12, 1974. Cutis, 15, 535.
11.
VerbovJ (1976) The place of intralesional steroid therapy in dermatology. British Journal of Dermatology94, (Suppl 12), 51.